KGP-25
Product Specifications
Target
Sodium Channel, GABA Receptor
Related Pathways
Membrane transporter/Ion channel, Neuroscience
Bioactivity
KGP-25 is an inhibitor of the voltage-gated sodium channel 1.8 (Nav1.8), utilized for analgesia by targeting the peripheral nervous system (PNS) . Additionally, it targets the γ-aminobutyric acid subtype A receptor (GABAA) in the central nervous system (CNS) for use as a general anesthetic.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6360354-01 0.2 mL
TXNDC5, ID (TXNDC5, TLP46, Thioredoxin domain-containing protein 5, Endoplasmic reticulum resident protein 46, Thioredoxin-like protein p46) (AP)
Sign In for Pricing
View Details MBS6360354-02 5x 0.2 mL
TXNDC5, ID (TXNDC5, TLP46, Thioredoxin domain-containing protein 5, Endoplasmic reticulum resident protein 46, Thioredoxin-like protein p46) (AP)
Sign In for Pricing
View Details